共 133 条
- [1] Fujimura M(2022)2021 Japanese guidelines for the management of moyamoya disease: guidelines from the research committee on moyamoya disease and Japan Stroke Society Neurol Med Chir (Tokyo) 62 165-170
- [2] Bao XY(2023)Chinese expert consensus on the treatment of MMD Chin Neurosurg J 9 5-68
- [3] Duan L(2015)Moyamoya disease and syndromes: from genetics to clinical management Appl Clin Genet 8 49-e334
- [4] Guey S(2020)Surgical designs of revascularization for moyamoya disease: 15 years of experience in a single center World Neurosurg 139 e325-1238
- [5] Tournier-Lasserve E(2020)A critical appraisal of bypass surgery in moyamoya disease Ther Adv Neurol Disord 13 1756286420921092-502
- [6] Herve D(1981)Encephalo-myo-synangiosis (EMS) in moyamoya disease Neurol Med Chir 21 1229-15
- [7] Kossorotoff M(2016)Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults J Neurosurg 127 492-294
- [8] Araki Y(1983)Treatment of moyamoya disease by temporal muscle graft 'encephalo-myo-synangiosis' Childs Brain 10 1-259
- [9] Moussouttas M(2012)Bypass surgery for moyamoya disease: concept and essence of surgical techniques Neurol Medico Chir 52 287-147
- [10] Rybinnik I(2015)Outcome of revascularization in moyamoya disease: evaluation of a new angiographic scoring system Asian J Neurosurg 10 252-49